Inhibrx Biosciences, Inc.
INBX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002007919
In the last 90 days, Inhibrx Biosciences, Inc. insiders filed 6 open-market purchases and 2 sales; 162 institutions reported holding it in 13F filings for Q2 2026, worth $1.36B in total; Viking Global Investors is the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Inhibrx Biosciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 61 | 66 | +5 |
| Shares | 19.6M | 20.5M | +873.8K (+4.5%) |
| Value | $538.8M | $681.6M | +$142.8M (+26.5%) |
New holders (9)
Institutions that held Inhibrx Biosciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 300,000 | $9.99M | 0.02% |
| Schroder Investment Management Group | 92,663 | $3.09M | 0.00% |
| Boothbay Fund Management, LLC | 29,218 | $973.0K | 0.04% |
| Mirabella Financial Services LLP | 10,840 | $361.0K | 0.05% |
| SG Americas Securities, LLC | 10,671 | $355.0K | 0.00% |
| State Board of Administration of Florida Retirement System | 6,131 | $204.0K | 0.00% |
| TCI Wealth Advisors, Inc. | 105 | $3.00K | 0.00% |
| Signaturefd, LLC | 22 | $1.00K | 0.00% |
| Parallel Advisors, LLC | 29 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Inhibrx Biosciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Farallon Capital Management, L.L.C. | 569,328 | $15.7M |
| Maven Securities LTD | 15,800 | $439.0K |
| Marshall Wace, LLP | 12,078 | $332.0K |
| STRS Ohio | 2,000 | $55.0K |